MedTrace Logo

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

NCT03599739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 598

Last updated 2023-03-16

No results posted yet for this study

Summary

The purpose of this study is to determine if different influenza vaccines produce different outcomes in nursing facility residents receiving the required annual influenza vaccination.

Conditions

  • Influenza
  • Influenza-like Illness
  • Influenza, Human

Interventions

BIOLOGICAL

Influenza

Facilities will be asked to complete a survey to evaluate the impact of the influenza vaccine choice on hospitalization risk for the 2017-2018 influenza season.

Sponsors & Collaborators

  • Seqirus

    collaborator INDUSTRY

  • Brown University

    collaborator OTHER

  • Insight Therapeutics, LLC

    lead OTHER

Principal Investigators

  • Stefan Gravenstein, MD, MPH · Brown University

  • Vincent Mor, PhD · Brown University

  • Pedro Gozalo, Phd · Brown University

  • H. Edward Davidson, PharmD, MPH · Insight Therapeutics, LLC

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-13
Primary Completion
2019-02-15
Completion
2023-01-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03599739 on ClinicalTrials.gov